New method for reducing tumorigenicity in induced pluripotent stem-cell based therapies

The potential for clinical use of induced pluripotent stem cell technology for transplant-based therapeutic strategies has previously been hindered by the risk of dysregulated cell growth, specifically the development of tumors.

http://ift.tt/1paNFTc